scholarly article | Q13442814 |
P2093 | author name string | Anna Hsu | |
Jennifer L Strande | |||
Jidong Su | |||
John E Baker | |||
Michael E Widlansky | |||
JingLi Wang | |||
Kasi V Routhu | |||
Nikos E Tsopanoglou | |||
P2860 | cites work | Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. | Q50773580 |
Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. | Q52024504 | ||
Preconditioning in immature rabbit hearts: role of KATP channels. | Q52035110 | ||
Myogenic activation of canine small renal arteries after nonchemical removal of the endothelium | Q72101555 | ||
Increased tolerance of the chronically hypoxic immature heart to ischemia. Contribution of the KATP channel | Q73120322 | ||
Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK | Q73427282 | ||
Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart | Q73702803 | ||
Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries | Q74160974 | ||
Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis | Q79802753 | ||
Ischemic preconditioning protects by activating prosurvival kinases at reperfusion | Q80546877 | ||
Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers | Q28580965 | ||
Hypoxia-induced preconditioning in adult stimulated cardiomyocytes is mediated by the opening and trafficking of sarcolemmal KATP channels | Q33201591 | ||
3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium. | Q33262306 | ||
Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling | Q34108989 | ||
NO stimulation of ATP-sensitive potassium channels: Involvement of Ras/mitogen-activated protein kinase pathway and contribution to neuroprotection. | Q34337942 | ||
cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. | Q34831503 | ||
The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles | Q35546222 | ||
Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol | Q35872144 | ||
AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K(+) channels | Q36247802 | ||
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. | Q36836773 | ||
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts | Q37617543 | ||
Protective effects of adenosine in the reversibly injured heart | Q40484139 | ||
Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase | Q40713421 | ||
Potentiation by nitric oxide of the ATP-sensitive K+ current induced by K+ channel openers in guinea-pig ventricular cells | Q43170437 | ||
Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels | Q43573741 | ||
Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion | Q43852730 | ||
The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart | Q44088321 | ||
Mechanism of thrombin-induced vasodilation in human coronary arterioles | Q44321359 | ||
Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways | Q44330669 | ||
Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection | Q44575126 | ||
Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism | Q44814393 | ||
Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury | Q44875207 | ||
Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning | Q44974883 | ||
Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. | Q45032159 | ||
A role for thrombin receptor signaling in endothelial cells during embryonic development | Q46345481 | ||
Inotropic, vasodilating and preconditioning actions of levosimendan in the heart | Q46351998 | ||
Localizing extracellular signal-regulated kinase (ERK) in pharmacological preconditioning's trigger pathway | Q46800668 | ||
Protein S-nitrosylation: a role of nitric oxide signaling in cardiac ischemic preconditioning. | Q46947186 | ||
Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart | Q47769993 | ||
The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical. | Q50506897 | ||
Endotoxin-induced nonendothelial nitric oxide activates the Ca(2+)-activated K+ channel in cultured vascular smooth muscle cells. | Q50768353 | ||
P433 | issue | 2 | |
P921 | main subject | reperfusion injury | Q1413991 |
P304 | page(s) | 325-334 | |
P577 | publication date | 2009-04-20 | |
P1433 | published in | Cardiovascular Research | Q4642329 |
P1476 | title | Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury | |
P478 | volume | 83 |
Q37685882 | Anti-Parstatin Promotes Angiogenesis and Ameliorates Left Ventricular Dysfunction during Pressure Overload |
Q34082171 | Cardioprotection from ischemia-reperfusion injury by near-infrared light in rats |
Q41987407 | Nerve growth factor reduces myocardial ischemia/reperfusion injury in rat hearts. |
Q30513467 | Nitric oxide synthase-dependent vasodilation of human subcutaneous arterioles correlates with noninvasive measurements of endothelial function |
Q44305776 | Parstatin prevents renal injury following ischemia/reperfusion and radiocontrast administration. |
Q33824563 | Parstatin, a novel protease-activated receptor 1-derived inhibitor of angiogenesis |
Q35064542 | Protease-activated receptors and myocardial infarction |
Q52888065 | The protease-activated receptor 1 possesses a functional and cleavable signal peptide which is necessary for receptor expression. |